APA (7th ed.) Citation

Geoerger, B., Marshall, L. V., Nysom, K., Makin, G., Bouffet, E., Defachelles, A., . . . Ziegler, D. S. (2023). Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial. European Journal of Cancer, 188, 8. https://doi.org/10.1016/j.ejca.2023.04.007

Chicago Style (17th ed.) Citation

Geoerger, Birgit, et al. "Afatinib in Paediatric Patients with Recurrent/refractory ErbB-dysregulated Tumours: Results of a Phase I/expansion Trial." European Journal of Cancer 188 (2023): 8. https://doi.org/10.1016/j.ejca.2023.04.007.

MLA (9th ed.) Citation

Geoerger, Birgit, et al. "Afatinib in Paediatric Patients with Recurrent/refractory ErbB-dysregulated Tumours: Results of a Phase I/expansion Trial." European Journal of Cancer, vol. 188, 2023, p. 8, https://doi.org/10.1016/j.ejca.2023.04.007.